MDMA plays a proactive role in helping to shape policy that impacts the medical device innovator. To achieve these goals, MDMA represents its members' collective interests before the United States Congress, the Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), and other federal agencies that develop or implement policies that affect the medical device industry. MDMA encourages its members to actively engage in the advocacy process through MDMA Working Group participation and grassroots mobilization.
